GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,604.50p
   
  • Change Today:
    -5.50p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.96m
  • Volume: 4,229,876
  • Market Cap: £66,506m
  • RiskGrade: 129

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
12-Jun-24 Shore Capital Buy 1,605.00p - - Reiteration
04-Jun-24 JP Morgan Cazenove Underweight 1,615.00p - - Reiteration
07-May-24 Barclays Equal-weight 1,761.00p - 1,725.00p Reiteration
02-May-24 JP Morgan Cazenove Underweight 1,728.50p 1,530.00p 1,660.00p Reiteration
01-May-24 Shore Capital Buy 1,705.00p - - Reiteration
17-Apr-24 Deutsche Buy 1,590.00p - 1,950.00p Reiteration
08-Apr-24 Barclays Equal-weight 1,620.00p - 1,725.00p Reiteration
12-Mar-24 Deutsche Buy 1,685.20p - 1,950.00p Reiteration
07-Mar-24 Shore Capital Buy 1,711.20p - - Reiteration
27-Feb-24 Deutsche Buy 1,671.00p - 1,950.00p Reiteration
15-Feb-24 Shore Capital Buy 1,663.00p - - Reiteration
14-Feb-24 Berenberg Bank Buy 1,668.00p 1,650.00p 1,820.00p Reiteration
09-Feb-24 Barclays Buy 1,660.00p - 1,950.00p Reiteration
31-Jan-24 Shore Capital Buy 1,568.00p - - Reiteration
18-Dec-23 Barclays Equal-weight 1,442.60p - 1,575.00p Reiteration
28-Nov-23 Citigroup Neutral 1,411.80p - - Reiteration
24-Nov-23 Berenberg Bank Buy 1,422.60p - 1,650.00p Reiteration
06-Nov-23 Barclays Equal-weight 1,405.00p - 1,575.00p Reiteration
11-Oct-23 Shore Capital Buy 1,519.20p - - Reiteration
03-Oct-23 Deutsche Buy 1,485.20p - - Reiteration
02-Oct-23 Citigroup Neutral 1,484.00p - - Reiteration
29-Sep-23 JP Morgan Cazenove Underweight 1,492.00p - - Reiteration
08-Sep-23 JP Morgan Cazenove Underweight 1,444.20p - - Reiteration
05-Sep-23 Deutsche Buy 1,381.40p - 1,700.00p Reiteration
04-Sep-23 Barclays Equal-weight 1,373.60p - 1,450.00p Reiteration
28-Jul-23 Berenberg Bank Buy 1,383.00p - 1,730.00p Reiteration
20-Jul-23 JP Morgan Cazenove Underweight 1,387.20p - - Reiteration
26-Jun-23 Citigroup Neutral 1,419.80p - 1,700.00p Reiteration
26-Jun-23 Jefferies Hold 1,419.80p - 1,575.00p Reiteration
16-Jun-23 Shore Capital Buy 1,364.60p - - Reiteration
14-Jun-23 JP Morgan Cazenove Underweight 1,363.40p - 1,400.00p Reiteration
08-Jun-23 Deutsche Buy 1,375.20p - 1,700.00p Reiteration
05-Jun-23 Berenberg Bank Buy 1,382.00p - 1,730.00p Reiteration
30-May-23 Citigroup Neutral 1,371.00p - - Reiteration
30-May-23 Deutsche Buy 1,371.00p - 1,700.00p Reiteration
16-May-23 Deutsche Buy 1,466.00p - 1,700.00p Reiteration
15-May-23 Shore Capital Buy 1,469.60p - - Reiteration
09-May-23 JP Morgan Cazenove Underweight 1,446.20p - - Reiteration
04-May-23 Shore Capital Buy 1,466.20p - - Reiteration
27-Apr-23 JP Morgan Cazenove Underweight 1,437.00p - 1,400.00p Reiteration
27-Apr-23 Barclays Equal-weight 1,437.00p - 1,450.00p Reiteration
27-Apr-23 Deutsche Buy 1,437.00p - 1,700.00p Reiteration
26-Apr-23 Shore Capital Buy 1,442.20p - - Reiteration
19-Apr-23 Berenberg Bank Buy 1,485.80p - 1,730.00p Reiteration
12-Apr-23 Shore Capital Buy 1,512.60p - - Reiteration
11-Apr-23 Barclays Equal-weight 1,506.40p - 1,450.00p Reiteration
04-Apr-23 Deutsche Buy 1,449.00p - 1,700.00p Reiteration
28-Mar-23 JP Morgan Cazenove Underweight 1,421.00p - - Reiteration
24-Mar-23 Shore Capital Buy 1,401.20p - - Reiteration
17-Mar-23 Deutsche Buy 1,400.80p 15,000.00p 17,000.00p Upgrade

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,604.50p
Change Today -5.50p
% Change -0.34 %
52 Week High 1,812.50
52 Week Low 1,316.00
Volume 4,229,876
Shares Issued 4,144.96m
Market Cap £66,506m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.34% below the market average54.34% below the market average54.34% below the market average54.34% below the market average54.34% below the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
Price Trend
31.01% above the market average31.01% above the market average31.01% above the market average31.01% above the market average31.01% above the market average
47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average
Income
21.31% above the market average21.31% above the market average21.31% above the market average21.31% above the market average21.31% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
20.43% below the market average20.43% below the market average20.43% below the market average20.43% below the market average20.43% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 8
Buy 4
Neutral 10
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 14-Jun-2024

Time Volume / Share Price
16:35 35,372 @ 1,604.50p
16:35 2,548 @ 1,604.50p
16:35 2,217,428 @ 1,604.50p
16:35 2,192 @ 1,604.50p
16:35 1,750 @ 1,604.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page